Ann: Preliminary Top-line Results from SMARTCOUGH-C Study, page-369

It is indeed a sad day for all Resapp holders. I've been anticipating this day for some time only to be let down by the dissapointing results and the poor trialling in the US.

This is my second biggest holding in my portfolio and it hurts to see it fall like this. I was bullish on this company but after these results, I have re-evaluated my position and believe it will be some time before the share price will reverse, if that even happens. Let today be a valuable learning lesson for all holders in the specs/disruptive tech play. I will continue to hold this in my portfolio as a constant reminder to always be vigilant when investing and ensure I do my careful due dilligence on any stock moving forward.